Homebiotech

biotech

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026

biotech

Engineered immune cells trial to fight colorectal cancer approved

Jim Cornall - September 16, 2026

biotech

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

Jim Cornall - September 16, 2026

biotech

Lotus Neuro launches to deliver therapies across blood-brain barrier

Jim Cornall - September 15, 2026

biotech

Asthma: New mechanism of action curbs asthma inflammatory response

Jim Cornall - July 22, 2026

biotech

Alzheimer’s Drug Discovery Foundation and Michael J. Fox Foundation launch $5m partnership

Jim Cornall - July 22, 2026

biotech

New approach to developing non-opioid painkillers

Jim Cornall - July 21, 2026

biotech

Atopic dermatitis trial meets primary endpoint

Jim Cornall - July 21, 2026

biotech

Key to immunotherapy for intractable brain tumours discovered

Jim Cornall - July 21, 2026

biotech

Fast Track Designation for colorectal cancer treatment

Jim Cornall - July 20, 2026

biotech

AI helps predict which DNA sequences bind to each other

Jim Cornall - July 20, 2026

biotech

Boost for Niagen’s NAD+ programme

Jim Cornall - July 20, 2026

1...91011...100 Page 10 of 100

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026 0

Revvity, Inc. has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specialising in human cell models and...

Engineered immune cells trial to fight colorectal cancer approved

biotech Jim Cornall - September 16, 2026 0

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

biotech Jim Cornall - September 16, 2026 0

Lotus Neuro launches to deliver therapies across blood-brain barrier

biotech Jim Cornall - September 15, 2026 0

Antibody targeting TSLP achieves positive results in asthma study

biotech Jim Cornall - September 15, 2026 0